Literature DB >> 30130491

Peptide ligand-based ELISA reagents for antibody detection.

Ewa Heyduk1, Rachel Hickey1, Nicola Pozzi1, Tomasz Heyduk2.   

Abstract

Detection of specific antibodies has numerous research, therapeutic and diagnostic applications. Short peptide ligands that bind specifically to antibodies with continuous epitopes can be derived from epitope mapping experiments. Short peptide ligands (mimotopes) specific to antibodies with discontinuous epitopes can be identified by screening complex peptide libraries. In an effort to enhance practical utility of such peptide ligands, we describe here a simple approach to turn such target antibody-specific peptide ligands into specific ELISA detection reagents. We show that a simple addition of biotinylated peptide ligands to commonly available horseradish peroxidase (HRP)-labeled streptavidin (or HRP-anti-biotin antibody), or digoxigenin-labeled peptides to HRP-anti-digoxigenin antibody detection reagents transformed these generic detection reagents into sensitive target antibody-specific reagents. ELISA assays performed using these reagents exhibited excellent analytical properties indicating their practical utility for antibody detection. One generic detection reagent can be readily transformed into many different specific ELISA reagents by a simple mix and match design using an appropriate target-specific peptide ligand. Simplicity of preparation of these ELISA reagents for detecting antibodies should facilitate their practical applications.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody; Detection; ELISA; Peptide

Mesh:

Substances:

Year:  2018        PMID: 30130491      PMCID: PMC6185743          DOI: 10.1016/j.ab.2018.08.012

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  27 in total

Review 1.  Antigenicity and immunogenicity of synthetic peptides.

Authors:  M H Van Regenmortel
Journal:  Biologicals       Date:  2001 Sep-Dec       Impact factor: 1.856

Review 2.  Autoantibodies in lupus: culprits or passive bystanders?

Authors:  Ole P Rekvig; Chaim Putterman; Cinzia Casu; Hua-Xin Gao; Anna Ghirardello; Elin S Mortensen; Angela Tincani; Andrea Doria
Journal:  Autoimmun Rev       Date:  2011-10-25       Impact factor: 9.754

Review 3.  Peptide Arrays: Development and Application.

Authors:  Lindsey C Szymczak; Hsin-Yu Kuo; Milan Mrksich
Journal:  Anal Chem       Date:  2017-12-05       Impact factor: 6.986

4.  Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.

Authors:  Mijke A Breukels; Els Jol-van der Zijde; Maarten J D van Tol; Ger T Rijkers
Journal:  Clin Infect Dis       Date:  2001-12-07       Impact factor: 9.079

5.  Accurate measurement of avidin and streptavidin in crude biofluids with a new, optimized biotin-fluorescein conjugate.

Authors:  G Kada; H Falk; H J Gruber
Journal:  Biochim Biophys Acta       Date:  1999-03-14

6.  Peptide inhibition of glomerular deposition of an anti-DNA antibody.

Authors:  B Gaynor; C Putterman; P Valadon; L Spatz; M D Scharff; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 7.  Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.

Authors:  Jian-Ying Zhang; Eng M Tan
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

8.  Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.

Authors:  Hailing Lu; Jon Ladd; Ziding Feng; Mei Wu; Vivian Goodell; Sharon J Pitteri; Christopher I Li; Ross Prentice; Samir M Hanash; Mary L Disis
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-19

Review 9.  Autoantibody profiling for cancer detection.

Authors:  Ji Qiu; Sam Hanash
Journal:  Clin Lab Med       Date:  2009-03       Impact factor: 1.935

Review 10.  Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.

Authors:  Michael A Partridge; Shobha Purushothama; Chinnasamy Elango; Yanmei Lu
Journal:  J Immunol Res       Date:  2016-07-31       Impact factor: 4.818

View more
  1 in total

1.  Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines.

Authors:  Sukrit Srivastava; Spyros D Chatziefthymiou; Michael Kolbe
Journal:  Methods Mol Biol       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.